These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 29085194)

  • 1. Evaluation of recurrence in gastric carcinoma: Comparison of contrast-enhanced computed tomography and positron emission tomography/computed tomography.
    Kim JH; Heo SH; Kim JW; Shin SS; Min JJ; Kwon SY; Jeong YY; Kang HK
    World J Gastroenterol; 2017 Sep; 23(35):6448-6456. PubMed ID: 29085194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting the recurrence of gastric cancer after curative resection: comparison of FDG PET/CT and contrast-enhanced abdominal CT.
    Kim DW; Park SA; Kim CG
    J Korean Med Sci; 2011 Jul; 26(7):875-80. PubMed ID: 21738339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Tumor ¹⁸F-FDG Avidity Affects the Performance of ¹⁸F-FDG PET/CT for Detecting Gastric Cancer Recurrence.
    Kim SJ; Cho YS; Moon SH; Bae JM; Kim S; Choe YS; Kim BT; Lee KH
    J Nucl Med; 2016 Apr; 57(4):544-50. PubMed ID: 26678615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma.
    Rayamajhi S; Balachandran A; Katz M; Reddy A; Rohren E; Bhosale P
    Abdom Radiol (NY); 2018 Feb; 43(2):505-513. PubMed ID: 28900703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of positron emission tomography/computed tomography in the management of patients with epithelial ovarian carcinoma after treatment.
    Nasu K; Abe W; Takai N; Tomonari K; Narahara H
    Arch Gynecol Obstet; 2011 May; 283(5):1121-6. PubMed ID: 20574659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of CT attenuation and F-18 fluorodeoxyglucose uptake of visceral adipose tissue for predicting survival in gastric cancer patients after curative surgical resection.
    Lee JW; Son MW; Chung IK; Cho YS; Lee MS; Lee SM
    Gastric Cancer; 2020 Mar; 23(2):273-284. PubMed ID: 31485803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical usefulness of F-18 FDG PET in lymphoepithelioma-like gastric carcinoma.
    Park S; Lee D; Lee KM; Han SU; Lee JH; Lee SJ; An YS; Yoon JK
    Eur J Radiol; 2017 Sep; 94():160-166. PubMed ID: 28712702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
    Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.
    Chen J; Cheong JH; Yun MJ; Kim J; Lim JS; Hyung WJ; Noh SH
    Cancer; 2005 Jun; 103(11):2383-90. PubMed ID: 15856477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
    Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
    Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of positron emission tomography/computed tomography in the evaluation of suspected recurrent ovarian cancer in the setting of normal CA-125 levels.
    Bhosale P; Peungjesada S; Wei W; Levenback CF; Schmeler K; Rohren E; Macapinlac HA; Iyer RB
    Int J Gynecol Cancer; 2010 Aug; 20(6):936-44. PubMed ID: 20683399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
    Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-Dimensional Image Fusion of
    Yu Y; Zhang WB; Liu XJ; Guo CB; Yu GY; Peng X
    J Oral Maxillofac Surg; 2017 Jun; 75(6):1301.e1-1301.e15. PubMed ID: 28320612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma.
    Li XF; Fu Q; Dong YW; Liu JJ; Song XY; Dai D; Zuo C; Xu WG
    World J Gastroenterol; 2016 Sep; 22(34):7787-96. PubMed ID: 27678362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of PET/CT in detection of gastric cancer recurrence.
    Sim SH; Kim YJ; Oh DY; Lee SH; Kim DW; Kang WJ; Im SA; Kim TY; Kim WH; Heo DS; Bang YJ
    BMC Cancer; 2009 Mar; 9():73. PubMed ID: 19250554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of CT and 18F-FDG pet for detecting peritoneal metastasis on the preoperative evaluation for gastric carcinoma.
    Lim JS; Kim MJ; Yun MJ; Oh YT; Kim JH; Hwang HS; Park MS; Cha SW; Lee JD; Noh SH; Yoo HS; Kim KW
    Korean J Radiol; 2006; 7(4):249-56. PubMed ID: 17143028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
    Kim CK; Park BK; Choi JY; Kim BG; Han H
    J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer: initial results.
    Sun L; Su XH; Guan YS; Pan WM; Luo ZM; Wei JH; Wu H
    World J Gastroenterol; 2008 Aug; 14(29):4627-32. PubMed ID: 18698676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.
    Lopez-Lopez V; Cascales-Campos PA; Gil J; Frutos L; Andrade RJ; Fuster-Quiñonero M; Feliciangeli E; Gil E; Parrilla P
    Eur J Radiol; 2016 Oct; 85(10):1824-1828. PubMed ID: 27666623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic performance of FDG PET/CT for surveillance in asymptomatic gastric cancer patients after curative surgical resection.
    Lee JW; Lee SM; Son MW; Lee MS
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):881-888. PubMed ID: 26611426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.